Literature DB >> 20489207

Repression of versican expression by microRNA-143.

Xiaobo Wang1, Guoqing Hu, Jiliang Zhou.   

Abstract

Smooth muscle cells (SMCs) retain remarkable plasticity to undergo phenotypic modulation in which the expression of smooth muscle markers is markedly attenuated while conversely expression of extracellular matrix (ECM) is dramatically up-regulated. Myocardin is perhaps the most potent transcription factor for stimulating expression of smooth muscle-specific genes; little is known, however, about whether myocardin can orchestrate ECM expression to act in concert with smooth muscle differentiation program. In this study, we demonstrated myocardin coordinate smooth muscle differentiation by inducing transcription of microRNA-143 (miR-143), which attenuates ECM versican protein expression. Previous studies have shown that versican is a chondroitin sulfate proteoglycan of the ECM that is produced by synthetic SMCs and promotes SMC migration and proliferation. Our data demonstrated that myocardin significantly represses versican expression in multiple cell lines, and this occurs through the induction of miR-143 by myocardin. By a modified reverse transcribed PCR, we found that miR-143 specifically binds to the 3'-untranslated region of versican mRNA. Reporter assays validated that miR-143 targets versican 3'-untranslated region through an evolutionarily conserved miR-143 binding site. Furthermore, overexpression of miR-143 significantly represses versican expression, whereas conversely, depletion of endogenous miR-143 results in up-regulation of versican expression. In addition, we demonstrated that myocardin represses versican through induction of miR-143. Finally, we found that the regulation of versican by miR-143 is involved in platelet-derived growth factor BB-induced SMC migration. This study provides the first evidence that myocardin, in addition to activating smooth muscle-specific genes, regulates ECM expression through induction of microRNAs during smooth muscle differentiation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20489207      PMCID: PMC2906317          DOI: 10.1074/jbc.M109.084673

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  Platelet-derived growth factor-BB-mediated activation of Akt suppresses smooth muscle-specific gene expression through inhibition of mitogen-activated protein kinase and redistribution of serum response factor.

Authors:  Nihal Kaplan-Albuquerque; Chrystelle Garat; Christina Desseva; Peter L Jones; Raphael A Nemenoff
Journal:  J Biol Chem       Date:  2003-07-25       Impact factor: 5.157

2.  Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor.

Authors:  D Wang; P S Chang; Z Wang; L Sutherland; J A Richardson; E Small; P A Krieg; E N Olson
Journal:  Cell       Date:  2001-06-29       Impact factor: 41.582

Review 3.  The extracellular matrix can regulate vascular cell migration, proliferation, and survival: relationships to vascular disease.

Authors:  E W Raines
Journal:  Int J Exp Pathol       Date:  2000-06       Impact factor: 1.925

4.  Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation.

Authors:  Kevin L Du; Hon S Ip; Jian Li; Mary Chen; Frederic Dandre; William Yu; Min Min Lu; Gary K Owens; Michael S Parmacek
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

5.  Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster.

Authors:  Thomas Boettger; Nadine Beetz; Sawa Kostin; Johanna Schneider; Marcus Krüger; Lutz Hein; Thomas Braun
Journal:  J Clin Invest       Date:  2009-08-17       Impact factor: 14.808

Review 6.  Serum response factor: toggling between disparate programs of gene expression.

Authors:  Joseph M Miano
Journal:  J Mol Cell Cardiol       Date:  2003-06       Impact factor: 5.000

7.  The SWI/SNF chromatin remodeling complex regulates myocardin-induced smooth muscle-specific gene expression.

Authors:  Jiliang Zhou; Min Zhang; Hong Fang; Omar El-Mounayri; Jennifer M Rodenberg; Anthony N Imbalzano; B Paul Herring
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-04-02       Impact factor: 8.311

8.  MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation.

Authors:  Yunhui Cheng; Xiaojun Liu; Jian Yang; Ying Lin; Da-Zhong Xu; Qi Lu; Edwin A Deitch; Yuqing Huo; Ellise S Delphin; Chunxiang Zhang
Journal:  Circ Res       Date:  2009-06-18       Impact factor: 17.367

9.  MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury.

Authors:  Mei Xin; Eric M Small; Lillian B Sutherland; Xiaoxia Qi; John McAnally; Craig F Plato; James A Richardson; Rhonda Bassel-Duby; Eric N Olson
Journal:  Genes Dev       Date:  2009-08-31       Impact factor: 11.361

10.  The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease.

Authors:  L Elia; M Quintavalle; J Zhang; R Contu; L Cossu; M V G Latronico; K L Peterson; C Indolfi; D Catalucci; J Chen; S A Courtneidge; G Condorelli
Journal:  Cell Death Differ       Date:  2009-10-09       Impact factor: 15.828

View more
  48 in total

Review 1.  microRNAs: tiny RNA molecules, huge driving forces to move the cell.

Authors:  Shenglin Huang; Xianghuo He
Journal:  Protein Cell       Date:  2010-11-09       Impact factor: 14.870

Review 2.  An overview of potential molecular mechanisms involved in VSMC phenotypic modulation.

Authors:  Ming-Jie Zhang; Yi Zhou; Lei Chen; Yan-Qin Wang; Xu Wang; Yan Pi; Chang-Yue Gao; Jing-Cheng Li; Li-Li Zhang
Journal:  Histochem Cell Biol       Date:  2015-12-26       Impact factor: 4.304

3.  Myocardin: new therapeutic agent in vascular disease?

Authors:  Xiaochun Long; Joseph M Miano
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-10       Impact factor: 8.311

4.  Developing vasculature and stroma in engineered human myocardium.

Authors:  Kareen L Kreutziger; Veronica Muskheli; Pamela Johnson; Kathleen Braun; Thomas N Wight; Charles E Murry
Journal:  Tissue Eng Part A       Date:  2011-02-02       Impact factor: 3.845

5.  Expression of V3 Versican by Rat Arterial Smooth Muscle Cells Promotes Differentiated and Anti-inflammatory Phenotypes.

Authors:  Inkyung Kang; Jeremy L Barth; Erin P Sproul; Dong Won Yoon; Gail A Workman; Kathleen R Braun; W Scott Argraves; Thomas N Wight
Journal:  J Biol Chem       Date:  2015-07-07       Impact factor: 5.157

6.  Neuronally produced versican V2 renders C-fiber nociceptors IB4 -positive.

Authors:  Oliver Bogen; Olaf Bender; Jana Löwe; Wolfgang Blenau; Beatrice Thevis; Wolfgang Schröder; Richard U Margolis; Jon D Levine; Ferdinand Hucho
Journal:  J Neurochem       Date:  2015-04-27       Impact factor: 5.372

7.  High Serum MiR-130a Levels Are Associated with Severe Perihematomal Edema and Predict Adverse Outcome in Acute ICH.

Authors:  Meng-Die Wang; Yong Wang; Yuan-Peng Xia; Jing-Wen Dai; Lin Gao; Si-Qi Wang; Hai-Jun Wang; Ling Mao; Man Li; Shi-Meng Yu; Yan Tu; Quan-Wei He; Guo-Peng Zhang; Lei Wang; Guo-Zheng Xu; Hai-Bo Xu; Ling-Qiang Zhu; Bo Hu
Journal:  Mol Neurobiol       Date:  2015-01-29       Impact factor: 5.590

8.  Expression of versican 3'-untranslated region modulates endogenous microRNA functions.

Authors:  Daniel Y Lee; Zina Jeyapalan; Ling Fang; Jennifer Yang; Yaou Zhang; Albert Y Yee; Minhui Li; William W Du; Tatiana Shatseva; Burton B Yang
Journal:  PLoS One       Date:  2010-10-25       Impact factor: 3.240

9.  miR-424/322 regulates vascular smooth muscle cell phenotype and neointimal formation in the rat.

Authors:  Elise Merlet; Fabrice Atassi; Rajender K Motiani; Nathalie Mougenot; Adeline Jacquet; Sophie Nadaud; Thierry Capiod; Mohamed Trebak; Anne-Marie Lompré; Alexandre Marchand
Journal:  Cardiovasc Res       Date:  2013-02-26       Impact factor: 10.787

Review 10.  miRNAs regulate expression and function of extracellular matrix molecules.

Authors:  Zina Jeyapalan Rutnam; Thomas N Wight; Burton B Yang
Journal:  Matrix Biol       Date:  2012-11-15       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.